935 related articles for article (PubMed ID: 15784015)
41. Differences in clinical characteristics between patients with non-erosive reflux disease and erosive esophagitis in Korea.
Ha NR; Lee HL; Lee OY; Yoon BC; Choi HS; Hahm JS; Ahn YH; Koh DH
J Korean Med Sci; 2010 Sep; 25(9):1318-22. PubMed ID: 20808675
[TBL] [Abstract][Full Text] [Related]
42. Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms.
Nam SY; Choi IJ; Ryu KH; Kim BC; Kim CG; Nam BH
Am J Gastroenterol; 2010 Oct; 105(10):2153-62. PubMed ID: 20571493
[TBL] [Abstract][Full Text] [Related]
43. Clinical features and endoscopic progression of gastroesophageal reflux disease.
Garrido Serrano A; Guerrero Igea FJ; Lepe Jiménez JA; Perianes Hernández C
Rev Esp Enferm Dig; 2003 Oct; 95(10):712-6, 707-11. PubMed ID: 14588065
[TBL] [Abstract][Full Text] [Related]
44. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea.
Kim N; Lee SW; Cho SI; Park CG; Yang CH; Kim HS; Rew JS; Moon JS; Kim S; Park SH; Jung HC; Chung IS;
Aliment Pharmacol Ther; 2008 Jan; 27(2):173-85. PubMed ID: 17973646
[TBL] [Abstract][Full Text] [Related]
45. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.
Wu AH; Tseng CC; Bernstein L
Cancer; 2003 Sep; 98(5):940-8. PubMed ID: 12942560
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of esophagitis in H. pylori-positive peptic ulcer disease and the impact of eradication therapy.
O'Connor HJ; McGee C; Ghabash NM; Cunnane K
Hepatogastroenterology; 2001; 48(40):1064-8. PubMed ID: 11490801
[TBL] [Abstract][Full Text] [Related]
47. Association between dinner-to-bed time and gastro-esophageal reflux disease.
Fujiwara Y; Machida A; Watanabe Y; Shiba M; Tominaga K; Watanabe T; Oshitani N; Higuchi K; Arakawa T
Am J Gastroenterol; 2005 Dec; 100(12):2633-6. PubMed ID: 16393212
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of endoscopic findings of erosive esophagitis in children: a population-based study.
Gilger MA; El-Serag HB; Gold BD; Dietrich CL; Tsou V; McDuffie A; Shub MD
J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):141-6. PubMed ID: 18664864
[TBL] [Abstract][Full Text] [Related]
49. No association between gallstones and gastroesophageal reflux disease.
Avidan B; Sonnenberg A; Schnell TG; Sontag SJ
Am J Gastroenterol; 2001 Oct; 96(10):2858-62. PubMed ID: 11693317
[TBL] [Abstract][Full Text] [Related]
50. Gastroesophageal pressure gradients in gastroesophageal reflux disease: relations with hiatal hernia, body mass index, and esophageal acid exposure.
de Vries DR; van Herwaarden MA; Smout AJ; Samsom M
Am J Gastroenterol; 2008 Jun; 103(6):1349-54. PubMed ID: 18510603
[TBL] [Abstract][Full Text] [Related]
51. Gastroscopy in immigrants of Turkish descent.
Wegman AI; Loffeld RJ
J Gastroenterol Hepatol; 2009 Jul; 24(7):1187-90. PubMed ID: 19476561
[TBL] [Abstract][Full Text] [Related]
52. The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy.
Veldhuyzen van Zanten SJ; Thomson AB; Barkun AN; Armstrong D; Chiba N; White RJ; Escobedo S; Sinclair P
Aliment Pharmacol Ther; 2006 Mar; 23(5):595-9. PubMed ID: 16480398
[TBL] [Abstract][Full Text] [Related]
53. [Higher prevalence of obesity in erosive gastroesophageal reflux disease].
Biccas BN; Lemme EM; Abrahão LJ; Aguero GC; Alvariz A; Schechter RB
Arq Gastroenterol; 2009; 46(1):15-9. PubMed ID: 19466304
[TBL] [Abstract][Full Text] [Related]
54. [Hiatal hernia as a risk factor for erosive esphagitis: experience and endoscopic findings of a Peruvian population with heartburn].
Tagle Arróspide M; Aguinaga Meza M; Vásquez Rubio G
Rev Gastroenterol Peru; 2003; 23(1):36-40. PubMed ID: 12768213
[TBL] [Abstract][Full Text] [Related]
55. Risk factors for erosive and non-erosive gastroesophageal reflux disease and Barrett's esophagus in Nothern Sardinia.
Dore MP; Pes GM; Bassotti G; Farina MA; Marras G; Graham DY
Scand J Gastroenterol; 2016 Nov; 51(11):1281-7. PubMed ID: 27381266
[TBL] [Abstract][Full Text] [Related]
56. Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study).
Nordenstedt H; Nilsson M; Johnsen R; Lagergren J; Hveem K
Helicobacter; 2007 Feb; 12(1):16-22. PubMed ID: 17241296
[TBL] [Abstract][Full Text] [Related]
57. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
[TBL] [Abstract][Full Text] [Related]
58. The incidence of reflux esophagitis among the Chinese.
Chang CS; Poon SK; Lien HC; Chen GH
Am J Gastroenterol; 1997 Apr; 92(4):668-71. PubMed ID: 9128320
[TBL] [Abstract][Full Text] [Related]
59. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496
[TBL] [Abstract][Full Text] [Related]
60. Different effects of dietary factors on reflux esophagitis and non-erosive reflux disease in 11,690 Korean subjects.
Nam SY; Park BJ; Cho YA; Ryu KH; Choi IJ; Park S; Kim YW
J Gastroenterol; 2017 Jul; 52(7):818-829. PubMed ID: 27848027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]